This is a Harvard Medical School online executive education program designed to provide business leaders with the knowledge, tools and strategies to design and implement technology-enabled change initiatives in health care.
This course will discuss specific examples of “non-oncology” drugs prescribed for co-morbidities such as hypertension or anxiety, which may have unexpected effects on tumor growth.